Histological AssessmeNt Determining EpitheliaL Response.
Chief investigator: Professor Janusz Jankowski
Sponsor: Queen Mary, University of London
Design: Observational/Interventional study collecting blood and tissue samples from patients recruited into Cancer Oesophagus Gefitinib-COG Study and blood samples from patient's family members with history of severe oesophagitis, Barrett's oesophagus and/or oesophageal cancer for genetic and molecular biological studies.
Planned /actual start date: 15/01/2010
Planned close date: 21/03/2014
Target number of patients: 1000
Number of patients recruited: Recruiting
Number of centres needed: 35
Number of centres recruiting: 1
(Manoj Nanji, Trial manager)